Loading
THE TREND OF STUDIES RELATED TO MYASTHENIA GRAVIS AND GENETICS IN VARIOUS POPULATIONS AROUND THE WORLD
##common.pageHeaderLogo.altText##
Vol. 5 No. 2 (2025) • Articles

THE TREND OF STUDIES RELATED TO MYASTHENIA GRAVIS AND GENETICS IN VARIOUS POPULATIONS AROUND THE WORLD

Published 2025-12-31
Dwiki Fitri , Lalu Muhammad Irham , Nanik Sulistyani , Wirawan Adikusuma , Rahman S Sianu , Muhammad Ma’ruf
Jurnal Farmasi Klinik dan Sains , Vol. 5, No. 2 (2025) , pp. 54-63 , Published: 2025-12-31
1 Universitas Muhammadiyah Gombong
2 Universitas Ahmad Dahlan

Abstract

Myasthenia gravis (MG) is an autoimmune disease involving the neuromuscular junction, mainly influenced by antibodies to acetylcholine receptors. In addition, antibodies to Muscle-Specific Kinase (MUSK), Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4). It is essential to determine publication trends regarding Myasthenia gravis because, currently, there are no studies that describe Myasthenia gravis publication trends related to genes in this field of study. Bibliometric analysis is used to see research trends, including frequently used keywords, most published journals, most cited publishers, author agencies, and collaboration between authors depicted in visualization using the VOSViewer application. Bibliometric analysis shows that the research trend is increasing from 1969 to 2023. The most frequently used keywords are myasthenia gravis, human, autoimmune disease, genetics, and article. The leading information related to the data is that the average annual publication is 5.89%, and the average citation for documents is 13.9%. Indonesia, as one of the countries experiencing Myasthenia gravis, has excellent potential to increase the number of research articles, which can be a means of exchanging knowledge, ideas, and technology and also has the potential for collaboration with other countries

Keywords

Myasthenia Gravis Autoimmune Genetic Bibliometric
Copyright (c) 2025 Dwiki Fitri

The copyright of the published manuscript belongs to the Author, while JFKS is given the right to publish and reproduce in part or in whole. All articles published by JFKS are open access content under the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license.

Authors who publish with this journal agree to the following terms:

  1. The author retains the copyright and the journal publishing rights simultaneously by granting a license under the Creative Commons Attribution License which allows others to share the work with a statement of authorship of the work and initial publication in this journal.
  2. Authors are allowed and permitted to save their articles on institutional repositories or on their websites, as well as other online repositories after articles are published on JFKS.

Downloads

Download data is not yet available.

References

  1. Alkabie, S., & Budhram, A. (2023). Prolonged Corticosteroids Without Maintenance Immunotherapy for Treatment of Anti-LGI1 Encephalitis: Analysis of Outcomes and Relapse Rate. Neurology(R) Neuroimmunology & Neuroinflammation, 10(3), 1–4. https://doi.org/10.1212/NXI.0000000000200115
  2. Alkhateeb, A., Fain, P. R., Thody, A., Bennett, D. C., & Spritz, R. A. (2003). Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Research, 16(3), 208–214. https://doi.org/10.1034/j.1600-0749.2003.00032.x
  3. Aria, M., & Cuccurullo, C. (2017). bibliometrix: An R-tool for comprehensive science mapping analysis. Journal of Informetrics, 11(4), 959–975. https://doi.org/10.1016/j.joi.2017.08.007
  4. Beghi, E., Antozzi, C., Batocchi, A. P., Cornelio, F., Cosi, V., Evoli, A., … Zarrelli, M. (1991). Prognosis of myasthenia gravis: A multicenter follow-up study of 844 patients. Journal of the Neurological Sciences, 106(2), 213–220. https://doi.org/10.1016/0022-510X(91)90260-E
  5. Berrih-Aknin, S., Frenkian-Cuvelier, M., & Eymard, B. (2014). Diagnostic and clinical classification of autoimmune myasthenia gravis. Journal of Autoimmunity, 48–49, 143–148. https://doi.org/10.1016/j.jaut.2014.01.003
  6. Bettini, M., Chaves, M., Cristiano, E., Pagotto, V., Perez, L., Giunta, D., & Rugiero, M. (2017). Incidence of Autoimmune Myasthenia Gravis in a Health Maintenance Organization in Buenos Aires, Argentina. Neuroepidemiology, 48(3–4), 119–123. https://doi.org/10.1159/000477733
  7. Eisenbarth, G. S., & Gottlieb, P. A. (2004). Medical progress: Autoimmune Polyendocrine Syndromes. The New England Journal of Medicine, 350(20), 2068–2079.
  8. Falagas, M. E., Pitsouni, E. I., Malietzis, G. A., & Pappas, G. (2008). Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. The FASEB Journal, 22(2), 338–342. https://doi.org/10.1096/fj.07-9492lsf
  9. Faulds, D., Goa, K. L., & Benfield, P. (1993). Cyclosporin: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Immunoregulatory Disorders. Drugs, 45(6), 953–1040. https://doi.org/10.2165/00003495-199345060-00007
  10. Golomb, B. A., & Evans, M. A. (2008). Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism. American Journal of Cardiovascular Drugs, 8(6), 373–418. https://doi.org/10.2165/0129784-200808060-00004
  11. Grob, D., Brunner, N., Namba, T., & Pagala, M. (2008). Lifetime course of myasthenia gravis. Muscle and Nerve, 37(2), 141–149. https://doi.org/10.1002/mus.20950
  12. Hoek, A., Schoemaker, J., & Drexhage, H. A. (1997). Premature Ovarian Failure and Ovarian Autoimmunity*. Endocrine Reviews, 18(1), 107–134. https://doi.org/10.1210/edrv.18.1.0291
  13. Irham, L. M., Adikusuma, W., & Perwitasari, D. A. (2022). Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach. Biochemistry and Biophysics Reports, 32(August), 101334. https://doi.org/10.1016/j.bbrep.2022.101334
  14. Irham, L. M., Perwitasari, D. A., Nuari, Y. R., Adikusuma, W., Dania, H., Maliza, R., … Cheung, R. (2023). Publication trend of TMPRSS2 as SARS-CoV-2 receptor during the COVID-19 pandemic. Pharmaciana, 13(1), 58. https://doi.org/10.12928/pharmaciana.v13i1.24052
  15. Jaretzki, A., Barohn, R. J., Ernstoff, R. M., Kaminski, H. J., Keesey, J. C., Penn, A. S., & Sanders, D. B. (2000). Myasthenia gravis: Recommendations for clinical research standards. Neurology, 55(1), 16–23. https://doi.org/10.1212/WNL.55.1.16
  16. Malathi, M., & Thappa, D. M. (2012). The intricacies of impact factor and mid-term review of editorship. Indian Journal of Dermatology, Venereology and Leprology, 78(1), 1–4. https://doi.org/10.4103/0378-6323.90938
  17. Oldstone, M. B. A. (1998). Molecular mimicry and immune-mediated diseases. The Faseb J, 1255–1265.
  18. Philips, L. (2003). The epidemiology of Miasthenya Gravis. Annals of the New York Academy of Sciences, 988(1), 407–412. Retrieved from https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1196/annals.1254.053
  19. Phillips, W. D., & Vincent, A. (2016). Pathogenesis of myasthenia gravis: Update on disease types, models, and mechanisms [version 1; referees: 2 approved]. F1000Research, 5(0), 1–10. https://doi.org/10.12688/F1000RESEARCH.8206.1
  20. Setyawati, T., Sujud, R. W., & Indriasari, I. (2020). Tata laksana ICU Krisis Miasthenia pada Pasien Tuberkulosis Paru dengan Penyulit Ventilator Associated Pneumonia (VAP). Jurnal Anestesi Perioperatif, 8(2), 131–140. https://doi.org/10.15851/jap.v8n2.2052
  21. Sweileh, W. M., AbuTaha, A. S., Sawalha, A. F., Al-Khalil, S., Al-Jabi, S. W., & Zyoud, S. H. (2017). Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015). Multidisciplinary Respiratory Medicine, 11(1), 1–16. https://doi.org/10.1186/s40248-016-0081-0
  22. Takai, T. (2002). Roles of Fc receptors in autoimmunity. Nature Reviews Immunology, 2(8), 580–592. https://doi.org/10.1038/nri856
  23. Trowsdale, J., & Knight, J. C. (2013). Major histocompatibility complex genomics and human disease. Annual Review of Genomics and Human Genetics, 14, 301–323. https://doi.org/10.1146/annurev-genom-091212-153455
  24. Whitacre, C. C. (2001). Sex differences in autoimmune disease. Nature Immunology, 2(9), 777–780. https://doi.org/10.1038/ni0901-777
  25. Zhong, M., Hunt, J. D., & Abraham, J. E. (2009). Modeling logistics and supply chain with an integrated land use transport model: PECAS. Proceedings of the 9th International Conference of Chinese Transportation Professionals, ICCTP 2009: Critical Issues in Transportation System Planning, Development, and Management, 358(46), 1300–1305. https://doi.org/10.1061/41064(358)182
Home Current Archives New Journal Search